Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

Journal:

Blood

Published:

2025-08-07

DOI:

10.1182/blood.2024027674

Affiliations:

5

Authors:

11

Go to article

Institutions	Authors	Share
The University of Alabama at Birmingham (UAB), United States of America (USA)	6.000000	0.55
Medical College of Wisconsin (MCW), United States of America (USA)	2.000000	0.18
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	1.000000	0.09
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.09
Vanderbilt University Medical Center (VUMC), United States of America (USA)	1.000000	0.09

Interested in Oncology and Carcinogenesis?